Datametrex AI Ltd V.DM

Alternate Symbol(s): DTMXF

Technology Information Technology Services

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from social media, news, blogs, forums, messengers, enterprise data, and the dark Web, creating predictive analytics. Cyber Security is a deep analytics platform that captures, structures, and visualizes vast amounts of unstructured social media data, which is used as a discovery tool that allows organizations to make decisions. It offers Nexa Products, which consists of NexaSecurity and NexaSMART. Healthcare consists of Imagine Health Centres, a multidisciplinary healthcare facility, and Medi-Call, a telehealth platform. The Company also offers a mobile blockchain game, Cereal Crunch.

TSXV:DM - Post by User

Datametrex AI Ltd > More details from the SAG-AFTRA (it's not good...)

<< Previous

Bullboard Posts

Next >>

Comment by TorlifTostorsonon Jul 21, 2021 11:54am

120 Views

Post# 33581465

RE:RE:More details from the SAG-AFTRA (it's not good...)

My speculation is different, as I assume increasing COVID numbers in autumn again. From then on, we will have again vaccination and testing, in comibination with a COVID pass, to handle the pandemic. I guess, the more people in autumn will have a cough, the more uncertainty will be about the cause of it. Testing will be necessary to make sure it's not COVID. So I think testing revenue will stay with DM until April 2022. Then it will deciline rapidly. But until then DM will have made a lot of cash with it.
JMHO
Torlif

Resilience19 wrote: We knew testing income would be dwindling at some point, so this doesn't come as a surprise. This said, here we're specifically talking about productions, so it may be that other testing sources will compensate for that income in Q3. Beyond September any testing income generated should only be seen as a boon and no longer the norm. This said, at the end of the day, we can be glad DM was able to jump on the COVID-19 bandwagon as it generated strong income streams while expanding the rollodex.

MomenTom wrote: https://www.sagaftra.org/files/sa_documents/Summary_COVIDProtocols.pdf?elqTrackId=75bf74fd2710448280cd51f5a8810bfd

Testing reduced to once a week or lower when Covid risk is low..

This is gonna hurt the revenues a lot, but most of that is already priced in I'd say.